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Microsporidia are obligate, intracellular, spore-forming protozoal parasites. Their host range
is extensive and includes most invertebrates and all classes of vertebrates. Five microsporidial
genera (Enterocytozoon, Encephalitozoon, Septata, Pleistophora, and Nosema) and unclassified
microsporidia have been associated with human disease, which appears to manifest primarily in
immunocompromised persons. The clinical manifestations of microsporidiosis are diverse and
include intestinal, pulmonary, ocular, muscular, and renal disease. The majority of microspo-
ridial infections in persons infected with human immunodeficiency virus (HIV) are attributed to
Enterocytozoon bieneusi, an important cause of chronic diarrhea and wasting. Four cases of
microsporidial infection among persons not infected with HIV who had documented or pre-
sumed cellular immunodeficiency and four cases of corneal stroma infection due to microspo-
ridia in immunocompetent patients have been described. Furthermore, the first case of traveler's
diarrhea due to E. bieneusi in an immunocompetent and otherwise healthy patient is reported in
this issue. The sources of human microsporidial infections and modes of transmission are un-
known.
Many microorganisms were first identified or gained atten-
tion as human pathogens when they were isolated from im-
munocompromised persons, particularly those infected with
the human immunodeficiency virus (HIV). Increased aware-
ness ofsuch organisms has often been facilitated by the devel-
opment of improved diagnostic techniques. The identifica-
tion of new pathogens in immunocompromised populations
often leads to the recognition that these agents may also
cause disease in immunocompetent persons. In this issue,
Sandfort and colleagues report what they believe is the first
case of intestinal microsporidial infection due to Enierocyto-
zoon bieneusi in an immunocompetent, HIV -seronegative pa-
tient with acute, self-limited traveler's diarrhea [I]. The mi-
crosporidial species E. bieneusi was first identified (by
transmission electron microscopy) in the case of a patient
with AIDS and diarrhea in 1985 [2] and has subsequently
been recognized as a frequent etiologic agent ofchronic diar-
rhea associated with HIV infection [3, 4].
The Organisms
The nontaxonomic term microsporidia. proposed in 1882
by Balbiani [5], relates to a group of organisms belonging to
the phylum Microspora, of the subkingdom Protozoa. Micro-
sporidia are small unicellular parasites that are considered
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true eukaryotes because they have a nucleus with a nuclear
envelope, because they have an intracytoplasmic membrane
system, and because their chromosomes are separated on mi-
totic spindles. Because microsporidia also exhibit certain
prokaryotic features (prokaryote-like ribosomal RNA and
absence of mitochondria. peroxisomcs. and Golgi mem-
branes), they are considered phylogenetically to be ancient
protozoa [6]. Microsporidia are obligate intracellular para-
sites and have no metabolically active stages outside the host
cell. A unique life cycle involving a proliferative merogonic
stage followed by a sporogonic stage results in distinctive and
resistant infective spores. Mature spores contain an excep-
tional tubular extrusion apparatus for injecting infective
sporular contents into the host cell [7].
Microsporidia have long been recognized as a cause of
disease in various animal groups and are one of the most
prevalent groups of parasites. with an extensive distribution
that includes most invertebrates and all classes of vertebrates
[8]. Since 1857. when Nageli first described newly identified
parasites in silkworms [9]. more than 100 microsporidial
genera and almost 1,000 species have now been identified
[l0].
The first human case of reasonably welI-documented rni-
crosporidial infection was reported in 1959 [I I]. To date.
five genera tEnterocvtozoon, Encephalitozoon. Septata. Pleis-
tophora, and Nosema), in addition to some as yet unclassified
microsporidia, have been associated with human disease.
which appears to predominantly affect immunocornpro-
mised persons. Only a few cases have been described among
persons not infected with HIV. Microsporidia have gained
increasing attention as important opportunistic pathogens in
the evolving pandemic of HIV infection. and over 400 cases
of HI V-associated microsporidial infection have been docu-
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mented. The potential sources and means of transmission of
human microsporidial infections are uncertain [3, 4, 7, 8,
12].
The taxonomy of microsporidia is complex and is chang-
ing rapidly under the scrutiny of molecular taxonomists. At
present, the taxonomic classification of microsporidia that
infect humans and other mammals is not conclusive, and
consensus is lacking about the exact number and names of
families and orders and the classification of genera within
families [7]. Until recently, Sprague's classification system,
proposed in 1977 and updated in 1982, was the most widely
used [7, 8]. Taxonomic criteria have primarily been based on
ultrastructural features, the configuration of the nuclei in
spores and in the developmental stages, the host-parasite in-
terface, and the number ofcoils ofthe tubular extrusion appa-
ratus. Species characteristics also included host-cell specific-
ity and patterns of organ, tissue, and cell involvement with
the parasite. In 1992, Sprague and colleagues proposed a
comprehensive revision in which differences in chromosome
cycles were treated as the most fundamental taxonomic char-
acteristics [10]. The authors commented that they deliber-
ately avoided the subject of evolutionary relationships be-
cause present knowledge is based on a limited number of
molecular studies. Nevertheless, recent data derived from
antigenic and molecular analysis of some microsporidial or-
ganisms suggest that ultrastructural examination of micro-
sporidia may not be appropriate for defining relationships of
genera and for differentiating species within a genus [7].
Therefore, current classification systems will likely be
amended significantly when results ofcomprehensive molec-
ular analyses become available.
Mechanism of Pathogenicity
A long-term evolutionary host-parasite interaction has re-
sulted in generally low pathogenicity of microsporidia in
most mammalian hosts, which usually manifests as latent or
mildly symptomatic infection. In mammalian Encephalito-
zoon cuniculi infection, the parasites are able to persist in
their hosts despite an active immune response. Latent infec-
tion remains asymptomatic as long as a balance between
multiplication of parasites and host immune response is
maintained [8]. Acute, potentially fatal encephalitozoonosis
has been observed in some neonatal mammals, particularly
when they have been infected transplacentally [8].
Microsporidial infection activates antibody production;
however, antibodies alone do not appear to yield protection.
The role of a competent cellular immune response in sup-
pressing microsporidial multiplication has been established
experimentally [13, 14]. In manifest encephalitozoonosis in
animals, the inflammatory reaction is typically an intense
diffuse cellular infiltration or granulomatous lesion charac-
terized by infiltrations of mononuclear cells including
lymphocytes, plasma cells, and macrophages, often around a
necrotic center. These lesions may persist after the disappear-
ance of the organisms themselves [8].
No animal model exists for infection due to the species E.
bieneusi. Current data on humans suggest that patients with
severe cellular immunodeficiency are at highest risk for devel-
oping microsporidial disease. It is not understood, however,
whether microsporidial infection in these patients is primar-
ilya reactivation oflatent infection acquired before immuno-
suppression occurs or whether microsporidial disease is
caused by recently acquired infection. In immunodeficient
patients, inflammatory reaction in tissue infected with mi-
crosporidia is often minimal or even absent. The pathophysi-
ology of human microsporidial infection is not sufficiently
understood [3, 4, 7].
Microsporidiosis in HIV-Infected Patients
E. bieneusi. which has thus far been detected only in hu-
mans, accounts for the majority of recognized microsporidial
infections in HIV-infected persons. Another microsporidial
species, Septata intestinalis, has recently been described as a
cause ofintestinal and disseminated infection in a small num-
ber of HIV-infected persons [15, 16]. Cases of Hl V-asso-
ciated encephalitozoonosis due to Encephalitozoon hellem
[17], and possibly E. cuniculi. are being recognized with in-
creasing frequency. The spectrum of recognized Encephalito-
zoon-associated disease in patients with AIDS appears to be
expanding and now includes keratoconjunctivitis, sinusitis,
bronchiolitis, nephritis, ureteritis, cystitis, hepatitis, and peri-
tonitis. [3, 4, 12, 17-23]. A single case of pieistophora myo-
sitis in a patient with AIDS has also recently been reported
[24].
E. bieneusi has frequently been determined to be the cause
ofchronic diarrhea and/or biliary illness in severely immuno-
deficient HIV-infected patients, particularly those with
CD4+ cell counts of <50-1 00/mm3 who have otherwise un-
explained chronic diarrhea [25-31]. Results of endoscopic
studies on patients with AIDS and chronic diarrhea, which
show prevalences of E. bieneusi that range from 7% to 50%,
may represent overestimation of the organism's occurrence
because of the selection bias often inherent in such studies.
Nevertheless, ongoing prospective studies of HIV-associated
chronic diarrhea indicate a substantial prevalence (9%-16%)
of E. bieneusi in patient groups who are evaluated using co-
prodiagnostic techniques to detect microsporidia [3, 4, 12,
28, 29]. E. bieneusi may also cause self-limited diarrhea in
Hl v-infectcd persons, particularly when cellular immunode-
ficiency is less severe [30]. Up to one-third of patients with
intestinal microsporidiosis are coinfected with other intes-
tinal pathogens; these coinfections may occur simulta-
neously or sequentially. When coinfection is present, the
pathogenic role of the etiologic agent may be difficult to as-
sess. However, the majority of epidemiologic and clinical
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studies show a strong correlation between the presence of
microsporidia and diarrheal disease [25, 26, 28-31].
Some investigators have questioned the causal association
between microsporidial infections and diarrhea. In a case-
control study in which intestinal biopsy results for 55 HIv-
infected patients who had chronic diarrhea were compared
with those for 51 HIV-infected patients who did not have
diarrhea, the investigators found no significant difference in
the occurrence of micros poridial infection in the two patient
groups [32]. However, these findings will require further eval-
uation because of the inadequate sample size of the study
and other possible methodical limitations. Some ongoing
studies of Hl.V-infected patients suggest the possibility of
asymptomatic enteric carriage of microsporidia preceding
wasting and/or diarrheal illness [30].
Diagnosis of Infection
Diagnosis of microsporidiosis currently depends on mor-
phological demonstration of the organisms themselves. Sero-
logical tests for detection of antibodies to Encephalitozoon
have been developed, but available results suggest that these
tests may not be feasible for diagnosis of human infection.
particularly in immunodeficient patients [33]. Progress is be-
ing made with respect to in vitro propagation of microspo-
ridia [34], which is crucial for developing immunofluores-
cence and serological assays as well as for testing the
effectiveness of antimicrosporidial drugs. Molecular probes
are also being developed but are currently not available out-
side research laboratories.
Detection of micros poridial parasites has often been based
on electron microscopic examination of tissue specimens be-
cause of the organisms' small size and staining properties.
which may hamper visualization of the spores and develop-
ing stages of the organism when routine staining techniques
are used. The small spores (the stages at which microsporidia
usually are identified) range in size from I to 2.5 J.Lm for most
species found in humans. With use of special staining tech-
niques, initial detection of microsporidia by light micro-
scopic examination of tissue sections and of more readily
obtainable specimens such as stool, duodenal aspirates, ur-
ine, sputum, nasal discharge, bronchoalveolar lavage fluid,
and conjunctival smears is now becoming routine practice
[3,4,12, 2\, 31, 35, 36]. Definitive identification of species
is made with use of a specific fluorescein-tagged antibody
(immunofluorescence) technique or electron microscopy [3,
4, 12].
A recently developed coprodiagnostic technique based on
chromotrope staining has been helpful in the diagnosis of
intestinal microsporidiosis in HIv-infected patients [31], and
-as reported in this issue by Sandfort and colleagues-also
appears to be useful in screening of stool specimens from
immunocompetent persons [1]. Chemofluorescent optical
brightening agents also stain microsporidial spores, but stain-
ing may not be specific [28]. Small fungal organisms may be
present in fecal specimens. and these orgalllsms as well as
other fecal elements may also be brightened: brightened mi-
crosporidial spores are not characterized by a specific mor-
phology [28].
Treatment of Microsporidiosis
Experience in therapy for microsporidiosis In Immunodefi-
cient patients is limited. and blinded. placebo-controlled
trials have not been performed. Preliminary observations of
the possible utility of albendazole for infections due to S.
intestinalis and Encephalitozoon species have been reported
[37,38]. In contrast, the success of therapy for intestinal E
bieneusi infection has been limited. Preliminary reports of a
good clinical response among patients treated with metroni-
dazole [26] could not be confirmed. In addition. treatment
with various other antibiotics or antiprotozoal drugs has
been attempted without success. Recent reports have sug.-
gested that in some cases treatment with albendazole rna)
lead to abatement of diarrhea and weight gam even though
parasites are still present in biopsy specimens of the small
intestine and microsporidial spores are still detected in stool
specimens obtained after treatment [39. 40!
Microsporidiosis in Patients Not Infected with HIV
Of patients not infected with HIv, four With systemic mi-
crosporidial infection and documented or presumed cellular
immunodeficiency due to causes other than AIDS have been
described so far. These patients include a child with svstermc
encephalitozoon infection and cellular Immunodeficiency 01
unknown etiology [41]: an athymic child \Ivnh systemic no-
serna infection [421: an adult male with myositis due to Pleis-
tophora species who had severe cellular immunodcficiencx
but remained HIV-seronegative during a -l-vear follow-up
[43.44]: and a child with systemic encephalitozoon infection
who may have had impaired immune response. as indicated
by cutaneous anergy to tuberculin antigen after vaccination
with BeG (bacille Calmette-Guerin) II II. In addition. four
immunocompetent and otherwise healthy patients with l:OI ..
neal stroma infection have been described [4";;--491.1'he OH-
nea may be considered an "immunoprivileged" site because
local immune response to infection in the cornea mav be less
intense than systemic response.
Some authors have speculated that rnicrosporidial species
such as E. bieneusi may be "natural" human parasites that
possibly cause transient diarrhea but norrnallv remain hclovv
the threshold of detection or clinical manifestation. as has
been observed with regard to other opportunistic protozoa in
patients with AIDS [50]. Indeed, prclirninurv reports have
indicated that microsporidial species first Identified in pa-
tients with AIDS will not be confined to this patient group
Intestinal E. bicncusi infection has been reported in Sl \ of
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593 African children with diarrhea and two of 397 children
without diarrhea who lived in an area with a low prevalence
of HIV, but the HIV serostatus of these children was not
determined [51]. Available epidemiologic data, however, are
too limited to suggest that residence or travel in tropical
countries increases one's risk for microsporidial infection.
The human infections that have been reported are globally
dispersed and have been documented in persons from all
continents except Antarctica [3, 4, 12].
In conclusion, the case of the immunocompetent patient
with traveler's diarrhea due to E. bieneusi presented by Sand-
fort et al. in this issue adds to our increasing knowledge ofthe
epidemiology of human microsporidial infections and sug-
gests that clinicians who evaluate patients with diarrheal ill-
ness that is potentially travel-related should now consider
intestinal microsporidiosis in their differential diagnoses.
References
I. Sandfort J, Hannemann A, Gelderblom H, Stark K, Owen RL Ruf B.
Enterocvtozoon bieneusi infection in an immunocompetent patient
who had acute diarrhea and who was not infected with the human
immunodeficiency virus. C1in Infect Dis 1994; 19:514-6.
2. Desportes L Le Charpentier Y, Galian A, et al. Occurrence of a new
microsporidan: Enterocvtozoon bieneusi n.g., n.sp., in the enterocytes
of a human patient with AIDS. J Protozool 1985; 32:250-4.
3. Bryan RT. Microsporidia. In: Mandell GL Bennett JE, Dolan R, eds.
Principles and practice of infectious diseases. 4th ed. New York:
Churchill Livingstone, 1994 (in press).
4. Weber R. Bryan RT. Schwartz DA, Owen RL. Human microsporidial
infections. Clin Microbiol Rev 1994 (in press).
5. Balbiani M. Sur les microsporidies ou psorospermies des articules.
Comptes rendus hebdomadaires des seances de l'Acadernie des
sciences (Paris) 1882; 95: I 168-71.
6. Vossbrinck CR, Maddux JV. Friedman S. Debrunner-Vossbrinck BA.
Woese CR. Ribosomal RNA sequence suggests microsporidia are
extremely ancient eukaryotes. Nature 1987; 326:411-4.
7. Canning EU. Microsporidia. In: Kreier JP. Baker JR. eds. Parasitic
protozoa. 2nd ed. Vol 6. New York: Academic Press. 1993.
8. Canning EU, Lom J, Dykova I. The microsporidia of vertebrates. New
York: Academic Press, 1986.
9. Nageli KW. Uber die neue Krankheit der Seidenraupe und verwandte
Organismen. Botanische Zeitung 1857; 15:760-1.
10. Sprague V. Becnel JJ. Hazard EI. Taxonomy of phylum microspora.
Crit Rev Microbiol 1992; 18:285-395.
II. Matsubayashi H. Koike T, Mikata T, Hagiwara S. A case of Encephali-
to~oon-Iike body infection in man. Arch Pathol 1959;67:181-7.
12. Bryan RT. Weber R. Microsporidia: emerging pathogens in immunode-
ficient persons [editorial]. Arch Pathol Lab Med 1993; 117: 1243-5.
13. Schmidt EC, Shadduck JA. Murine encephalitozoonosis model for
studying the host-parasite relationship of a chronic infection. Infect
Immun 1983; 40:936-42.
14. Schmidt EC, Shadduck JA. Mechanisms of resistance to the intracellu-
lar protozoan Encephalitozoon cuniculi in mice. J Immunol
1984; 133:2712-9.
15. Cali A. Kotler DP, Orenstein JM. Septata intestinalis N.G .. N.Sp., an
intestinal microsporidian associated with chronic diarrhea and dis-
semination in AIDS patients. J Protozool 1993; 40: 101-12.
16. Orenstein JM. Dieterich DT. Kotler DP. Systemic dissemination by a
newly recognized intestinal microsporidia species in AIDS. AIDS
1992;6:1143-50.
17. Didier ES, Didier PJ, Friedberg ON, et al. Isolation and characteriza-
tion ofa new human microsporidian, Encephalitozoon helleni (n.sp.),
from three AIDS patients with keratoconjunctivitis. J Infect Dis
1991; 163:617-21.
18. Schwartz DA Bryan RT, Hewan-Lowe KO, et al. Disseminated micro-
sporidiosis (Encephalitozoon hel/em) and acquired immunodeficiency
syndrome. Autopsy evidence for respiratory acquisition. Arch Pathol
Lab Med 1992; 116:660-8.
19. Schwartz DA. Visvesvara GS. Diesenhouse MC, et al. Ocular pathology
of microsporidiosis: role of immunofluorescent antibody for diagno-
sis of Encephalitozoon hellem in biopsies. smears, and intact globes
from seven AIDS patients. Am J Opththalmol 1993; 115:285-92.
20. Schwartz DA, Visvesvara GS, Leitch GJ, et al. Pathology of symptom-
atic microsporidial (Encephalitozoon hel/em) bronchiolitis in the ac-
quired immunodeficiency syndrome: a new respiratory pathogen
diagnosed from lung biopsy, bronchoalveolar lavage, sputum, and
tissue culture. Hum Pathol 1993;24:937-43.
21. Weber R, Kuster H, Visvesvara GS. Bryan RT. Schwartz DA, Luthy R.
Disseminated microsporidiosis due to Encephalitozoon helleni:pulmo-
nary colonization. microhematuria, and mild conjunctivitis in a pa-
tient with AIDS. Clin Infect Dis 1993; 17:415-9.
22. Terada S. Reddy KR. Jeffers LJ, Cali A. Schiff ER. Microsporidian
hepatitis in the acquired immunodeficiency syndrome. Ann Intern
Med 1987; 107:61-2.
23. Zender HO, Arrigoni E, Eckert J, Kapanci Y. A case ofEncephalitozoon
cuniculi peritonitis in a patient with AIDS. Am J Clin Pathol
1989; 92:352-6.
24. Chupp GL Alroy J. Adelman LS, Breen JC, Skolnik PRo Myositis due
to Pleistophora (microsporidia) in a patient ·;:~h AIDS. Clin Infect
Dis 1993; 16:15-21.
25. Orenstein JM. Chiang J. Steinberg W, Smith PD. Rotterdam H. Kotler
DP. Intestinal microsporidiosis as a cause ofdiarrhea in human immu-
nodeficiency virus-infected patients: A report of 20 cases. Hum
PathoI1990;21:475-81.
26. Eeftinck Schattenkerk JK, van Gool T. van Ketel RJ, et al. Clinical
significance ofsmall-intestinal microsporidiosis in HIV-I-infected in-
dividuals. Lancet 1991;337:895-8.
27. Pol S, Romana CA, Richard S, et al. Microsporidia infection in patients
with the human immunodeficiency virus and unexplained cholangi-
tis. N Engl J Med 1993; 328:95-9.
28. van Gool T. Snijders F. Reiss P, et al. Diagnosis ofintestinal and dissem-
inated microsporidial infections in patients with HIV by a new rapid
fluorescence technique. J Clin Pathol 1993;46:694-9.
29. Weber R, Vugia OJ. Juranek DO, et al. Prospective evaluation of diar-
rhea and enteric parasitosis in HIV / AIDS [abstract no 1527]. In:
Program and abstracts of the 32nd Interscience Conference on Anti-
microbial Agents and Chemotherapy (Anaheim, CA). Washington,
DC: American Society for Microbiology, 1992.
30. Weber R, Bryan T. Vugia OJ, Kaiser L. Sauer B, Luthy R. Clinical
manifestations and course of intestinal Enterocvtozoon bieneusi mi-
crosporidiosis [abstract WS-BI4-5]. In: Program and abstracts of the
9th International Conference on AIDS (Berlin). 1993.
31. Weber R. Bryan RT. Owen RL. Wilcox CM, Gorelkin L, Visvesvara
GS. Improved light-microscopical detection of microsporidia spores
in stool and duodenal aspirates. N Engl J Med 1992; 326: 161-6.
32. Rabeneck L. Gyorkey F. Genta RM, Gyorkey P, Foote LW, Risser JM.
The role of Microsporidia in the pathogenesis ofHI V-related chronic
diarrhea. Ann Intern Med 1993; 119:895-9.
33. Didier ES. Shadduck JA, Didier PJ, Millichamp N, Vossbrinck CR.
Studies on ocular microsporidia. J Protozoal 1991;38:635-8.
34. Visvesvara GS, Leitch GJ, Gorelkin L, Wilcox M, Weber R, Bryan RT.
Short-term in vitro culture of Enterocvtozoon bieneusi from four dif-
ferent patients with AIDS [abstract PO-BI0-1447]. In: Program and
CIO 1994: 19 (September) Microsporidial Infections 521
abstracts of the 9th International Conference on AIDS (Berlin).
1993.
35. Field A, Hing M, Milliken S, Marriott D. Microsporidia in the small
intestine of HI V-infected patients: a new diagnostic technique and a
new species. Med J Aust 1993: 158:390-4.
36. Weber R, Kuster H, Keller R. et al. Pulmonary and intestinal micro-
sporidiosis in a patient with the acquired immunodeficiency syn-
drome. Am Rev Respir Dis 1992; 146: 1603-5.
37. Orenstein JM, Dieterich DT, Kotler DP. Albendazole as a treatment
for disseminated microsporidiosis due to Septate intestinalis in AIDS
patients. In: Program and abstracts of the Workshop on Intestinal
Microsporidia in HIV Infection (Paris). Paris: INSERM, 1992.
38. Weber R, Sauer B. Spycher MA. et al. Detection of Septate intestinalis
in stool specimens and coprodiagnostic monitoring of successful
treatment with albendazole. Clin Infect Dis 1994; 19:342-5.
39. Dieterich DT. Lew EA. Kotler DP, Poles MA, Orenstein JM. Treat-
ment with albendazole for intestinal disease due to Enterocvtozoon
bieneusi in patients with AIDS. J Infect Dis 1994; 169: 178-83.
40. Blanshard Co Ellis DS. Tovey DG, Dowell S, Gazzard BG. Treatment
of intestinal rnicrosporidiosis with albendazole in patients with
AIDS. AIDS 1992;6:311-3.
41. Bergquist NR, Stintzing G, Smedman L, Waller T. Andersson T. Diag-
nosis of encephalitozoonosis in man by serological tests. Br Med J
1984; 288:902.
42. Margileth AM. Strano AJ, Chandra R. Neafie R, Blum M, McCully
RM. Disseminated nosernatosis in an immunologically compromised
infant. Arch PathoI1973;95:145-50.
43. Ledford DK, Overman MD. Gonzalvo A. Cali A. Mester W. l.ockev
RF. Microsporidiosis myositis in a patient with acquired immunodefi-
ciency syndrome. Ann Intern Med 1985: 102:62X-30.
44. Macher AM. Neafie R. Angritt P. Tuur SM. Microsporidial myositis
and the acquired immunodeficiency syndrome (AIDS): a four-year
follow-up [letter]. Ann Intern Med 1988; 109:343.
45. Ashton N. Wirasinha PA. Encephalitozoonosis (nosernatosis) of the
cornea. Br J Ophthalmol 1973; 57:669-74.
46. Pinnolis M, Egbert PRo Font RL Winter Fe. Nosematosis of the cur-
nea. Arch Ophthalmol 1981: 99: 1044-7.
47. Davis RM. Font RL Keisler MS, Shadduck JA Corneal microsporidio-
sis. A case report including ultrastructural observations Ophthalmol-
ogy 1990;97:953-7.
48. Shadduck JA. Meccoli RA. Davis R. Font RL. First isolation of a mi-
crosporidian from a human patient. J Infect Dis 1990: 162:773-6
49. Cali A. Meisler DM. Lowder CY. et a1. Corneal rnicrosporidioses: char-
acterization and identification. J Protozool 1991. 38:215S- 7S.
50. Canning EU, Hollister WS. Human infections with microsporidia Re-
views in Medical Microbiology 1992; 3:35-42.
51. Bretagne S. Foulet F. Alkassourn W. Fleury J. Develoux M. Prevalence
of micro sporidia spores in stools from children in Niamey. Niger. In
Program and abstracts of the Workshop on Intestinal Microsporidia
in HIV Infection (Paris). Paris: INSERM. 1992.
